Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4049 - 4056 of 11616 results
Congress Loosens Telehealth Reimbursement Restrictions in Response to Coronavirus, but State Law Practice Requirements Remain
March 17, 2020| Blog| Viewpoint
SEC Guidance for Annual Shareholders Meetings Affected by COVID-19
March 17, 2020| Advisory| Viewpoint
Law360's 2020 Access To Justice Editorial Advisory Board
March 17, 2020| News
New York Demands Coronavirus Emergency Plan from Crypto Firms by April 9th and Adds Requirements for Boards and CEOs
March 17, 2020| Blog| Viewpoint
Update from Washington – Coronavirus Response
March 17, 2020| Advisory| Viewpoint
Gender Mandate for Corporate Boards: A Year in Review
March 17, 2020| News
Federal Response to COVID-19
March 16, 2020| Alert| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.